Financhill
Back

Harmony Biosciences Holdings Quote, Financials, Valuation and Earnings

My #1 Coin is...

All the details are on the next page.
Sell
31

HRMY
Harmony Biosciences Holdings

Last Price:
30.26
Seasonality Move:
4.86%

7 Day Trial

ALL ACCESS PASS

$ 7

This DeFi Coin Could 10x Soon... I Advise You Get In Now!

Discover this DeFi diamond before the next surge

Harmony Biosciences Holdings Price Quote

$30.26
-0.65 (-2.1%)
(Updated: May 1, 2024 at 6:55 PM ET)

Harmony Biosciences Holdings Key Stats

Sell
31
Harmony Biosciences Holdings (HRMY) is a Sell

Day range:
$30.85 - $34.40
52-week range:
$18.61 - $39.27
Dividend yield:
0%
P/E ratio:
14.51
P/S ratio:
3.21
P/B ratio:
3.76%

Volume:
1.7M
Avg. volume:
404.9K
1-year change:
-4.13%
Market cap:
$1.8B
Revenue:
$582M
EPS:
$2.12

How Much Does Harmony Biosciences Holdings Make?

Is Harmony Biosciences Holdings Growing As A Company?

Harmony Biosciences Holdings Stock Price Performance

What Is Harmony Biosciences Holdings 52-Week High & Low?

Harmony Biosciences Holdings Price To Free Cash Flow

Is It Risky To Buy Harmony Biosciences Holdings?

Is Harmony Biosciences Holdings Cash Flow Positive?

  • What Is HRMY Cash Flow From Operations?
    Cash flow from operations (TTM) is $219.4M
  • What Is Harmony Biosciences Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$105.6M
  • What Is Harmony Biosciences Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$46.4M

Harmony Biosciences Holdings Return On Invested Capital

  • Is Management Doing A Good Job?
    HRMY return on invested capital is 19.86%
  • What Is Harmony Biosciences Holdings Return On Assets?
    ROA measures how assets are converting to revenues and is 17.23%
  • What Is HRMY Return On Equity?
    ROE is a measure of profitability and is 28.27%

Harmony Biosciences Holdings Earnings Date & Stock Price

Harmony Biosciences Holdings Competitors

Harmony Biosciences Holdings Dividend Yield

Data Unavailable

Harmony Biosciences Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: -43.04% 26.92%
Revenue: 31.26% 0.18%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 41.38
Upside from Last Price: 33.86%

Major Shareholders

  • How many HRMY shares are owned by institutional investors?
    70.3M HRMY shares are owned by institutional investors
  • How many HRMY shares are owned by insiders?
    267.5K HRMY shares are owned by insiders